SCHEMBL6773714

SCHEMBL6773714

CC(O)CCCCCCCC/C=C/n1c(=O)c2c(ncn2C)n(C)c1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 8/20 0.46
ACHE P22303 2/20 0.46
PIK3CD O00329 1/20 0.46
POLB P06746 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
CNR1 P21554 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
NTSR1 P30989 1/20 0.46
MC3R P41968 1/20 0.46
NOTUM Q6P988 1/20 0.46
SIRT3 Q9NTG7 1/20 0.46
GDA Q9Y2T3 1/20 0.46
NR2E1 Q9Y466 1/20 0.46
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TNF P01375 3/20 0.43
USP2 O75604 1/20 0.43
CYP1A2 P05177 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6773717 1.00 ADORA2B (0.46) ADORA2BACHEPIK3CDPOLBADORA3
SCHEMBL8076046 0.85 ADORA2B (0.51) ADORA2BACHEPIK3CDPOLBADORA3
SCHEMBL8952269 0.85 ADORA2B (0.51) ADORA2BACHEPIK3CDPOLBADORA3
SCHEMBL8072026 0.85 ADORA2B (0.51) ADORA2BACHEPIK3CDPOLBADORA3
SCHEMBL9295135 0.83 ADORA2B (0.52) ADORA2BACHEPIK3CDPOLBADORA3
SCHEMBL8699282 0.80 ADORA2B (0.66) ADORA2BACHELMNASMN1; SMN2TNF
SCHEMBL6778919 0.80 ADORA2B (0.66) ADORA2BACHELMNASMN1; SMN2TNF
SCHEMBL6778207 0.80 ADORA2B (0.66) ADORA2BACHELMNASMN1; SMN2TNF
SCHEMBL8700060 0.80 ADORA2B (0.66) ADORA2BACHELMNASMN1; SMN2TNF
SCHEMBL6774460 0.80 ADORA2B (0.66) ADORA2BACHELMNASMN1; SMN2TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6693105-B1 USING XANTHINYL DERIVATIVES TO REDUCE TREATMENT INDUCED TOXICITY; INHIBITING CELLULAR SIGNALING THROUGH SECOND MESSENGER PATHWAY; REDUCING CELLULAR LEVEL OF NONARACHI-DONATE PHOSPHATIDIC ACID AND DIACYLGLYCEROL CELL THERAPEUTICS, INC. 2004-02-17 US disclosed
US-6133274-A TREATING DISEASE MEDIATED BY INTRACELLULAR SIGNALING THROUGH ONE OR TWO SPECIFIC INTRACELLULAR SIGNALING PATHWAYS; A XANTHINYL HAVING AT LEAST ONE NITROGEN SUBSTITUTED BY AN HYDROXYALKYL; ANTITUMOR,-CARCINOGENIC,-ARTHRITIC AGENTS CELL THERAPEUTICS, INC. (US) 2000-10-17 US disclosed
US-5780476-A ADMINISTERING TO TREAT INFLAMMATORY DISEASE AND RHEUMATOID ARTHITIS CELL THERAPEUTICS, INC. (US) 1998-07-14 US disclosed